{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MD simulations", "Omicron", "SARS-CoV-2", "bioinformatics", "medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35205124", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "07"}], "Language": ["eng"], "ELocationID": ["258", "10.3390/biology11020258"], "Journal": {"ISSN": "2079-7737", "JournalIssue": {"Volume": "11", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "07"}}, "Title": "Biology", "ISOAbbreviation": "Biology (Basel)"}, "ArticleTitle": "Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach.", "Abstract": {"AbstractText": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to inflict chaos globally. The emergence of a novel Omicron variant (B.1.1.529) in South Africa harbors 30 mutations in the spike protein. The variant is distinguished from other variants of concern (VOCs) with an increased (15) number of mutations in the receptor-binding domain (RBD) and suggests higher chances of causing reinfections. Initial reports also claimed that this variant escapes all the neutralizing antibodies, thus demanding a novel strategy against it. Thus, in this study, we performed a computational molecular screening against the RBD of the Omicron (B.1.1.529) variant and assessed the binding affinity of potent drugs against the RBD. The multi-steps screening of the South African Natural Compounds Database (SANCDB) revealed four medicinal compounds as excellent (potential) anti-viral agents against the Omicron variant, namely SANC00944, SANC01032, SANC00992, and SANC00317. The simulation analysis of these compounds in complex with the RBD demonstrated stable dynamics and structural compactness. Moreover, the residual flexibility analysis revealed that the flexibility of three loops required for interaction with hACE2 has been reduced by the binding of these drugs. The post-simulation validation of these compounds such as binding free energy, in silico bioactivity, and dissociation constant prediction validated the anti-viral potency of these compounds. The total binding free energy (TBFE) for the SANC01032-RBD complex was reported to be -46.54 kcal/mol; for the SANC01032-RBD complex, the TBFE was -41.88 kcal/mol; for the SANC00992-RBD complex the TBFE was -29.05 kcal/mol, while for the SANC00317-RBD complex the TBFE was -31.03 kcal/mol. The results showed the inhibition potential of these compounds by targeting the RBD. In conclusion, this study will help in the design and discovery of novel drug therapeutics, which may be used against the emerging Omicron variant of SARS-CoV-2."]}, "AuthorList": [{"Identifier": ["0000-0003-2101-8800"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 61481, Saudi Arabia."}], "LastName": "Hakami", "ForeName": "Abdulrahim R", "Initials": "AR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biology (Basel)", "NlmUniqueID": "101587988", "ISSNLinking": "2079-7737"}, "CoiStatement": "The author declares no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020;10:313\u2013319. doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Has\u00f6ks\u00fcz M., Kili\u00e7 S., Sara\u00e7 F. Coronaviruses and SARS-COV-2. Turk. J. Med. Sci. 2020;50:549\u2013556. doi: 10.3906/sag-2004-127.", "ArticleIdList": ["10.3906/sag-2004-127", "PMC7195990", "32293832"]}, {"Citation": "Tahir ul Qamar M., Rehman A., Tusleem K., Ashfaq U.A., Qasim M., Zhu X., Fatima I., Shahid F., Chen L.-L. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches. PLoS ONE. 2020;15:e0244176. doi: 10.1371/journal.pone.0244176.", "ArticleIdList": ["10.1371/journal.pone.0244176", "PMC7755200", "33351863"]}, {"Citation": "Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Peacock S.J. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021;19:409\u2013424. doi: 10.1038/s41579-021-00573-0.", "ArticleIdList": ["10.1038/s41579-021-00573-0", "PMC8167834", "34075212"]}, {"Citation": "Abdool Karim S.S., de Oliveira T. New SARS-CoV-2 variants\u2014clinical, public health, and vaccine implications. N. Engl. J. Med. 2021;384:1866\u20131868. doi: 10.1056/NEJMc2100362.", "ArticleIdList": ["10.1056/NEJMc2100362", "PMC8008749", "33761203"]}, {"Citation": "Choi J.Y., Smith D.M. SARS-CoV-2 Variants of Concern. Yonsei Med. J. 2021;62:961. doi: 10.3349/ymj.2021.62.11.961.", "ArticleIdList": ["10.3349/ymj.2021.62.11.961", "PMC8542474", "34672129"]}, {"Citation": "Muhseen Z.T., Hameed A.R., Al-Hasani H.M., ul Qamar M.T., Li G. Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach. J. Mol. Liq. 2020;320:114493. doi: 10.1016/j.molliq.2020.114493.", "ArticleIdList": ["10.1016/j.molliq.2020.114493", "PMC7538380", "33041407"]}, {"Citation": "Tahir ul Qamar M., Shahid F., Aslam S., Ashfaq U.A., Aslam S., Fatima I., Fareed M.M., Zohaib A., Chen L.-L. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect. Dis. Poverty. 2020;9:1\u201314. doi: 10.1186/s40249-020-00752-w.", "ArticleIdList": ["10.1186/s40249-020-00752-w", "PMC7492789", "32938504"]}, {"Citation": "Tortorici M.A., Veesler D. Structural insights into coronavirus entry. Adv. Virus Res. 2019;105:93\u2013116. doi: 10.1016/bs.aivir.2019.08.002.", "ArticleIdList": ["10.1016/bs.aivir.2019.08.002", "PMC7112261", "31522710"]}, {"Citation": "Tu H., Avenarius M.R., Kubatko L., Hunt M., Pan X., Ru P., Garee J., Thomas K., Mohler P., Pancholi P., et al. Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio. bioRxiv. 2021 doi: 10.1101/2021.01.12.426407.", "ArticleIdList": ["10.1101/2021.01.12.426407"]}, {"Citation": "Walls A.C., Park Y.-J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281\u2013292.e286. doi: 10.1016/j.cell.2020.02.058.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Khan A., Wei D.-Q., Kousar K., Abubaker J., Ahmad S., Ali J., Al-Mulla F., Ali S.S., Nizam-Uddin N., Sayaf A.M. Preliminary Structural Data Revealed that the SARS-CoV-2 B. 1.617 Variant\u2019s RBD binds to ACE2 receptor stronger than the Wild Type to Enhance the Infectivity. ChemBioChem. 2021;22:2641\u20132649. doi: 10.1002/cbic.202100191.", "ArticleIdList": ["10.1002/cbic.202100191", "PMC8426803", "34160124"]}, {"Citation": "Khan A., Gui J., Ahmad W., Haq I., Shahid M., Khan A.A., Shah A., Khan A., Ali L., Anwar Z., et al. The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD\u2013ACE2 binding affinity and is an antibody escaping variant: A computational structural perspective. RSC Adv. 2021;11:30132\u201330147. doi: 10.1039/D1RA04694B.", "ArticleIdList": ["10.1039/D1RA04694B"]}, {"Citation": "Khan A., Khan T., Ali S., Aftab S., Wang Y., Qiankun W., Khan M., Suleman M., Ali S., Heng W. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Biomed. Pharmacother. 2021;143:112176. doi: 10.1016/j.biopha.2021.112176.", "ArticleIdList": ["10.1016/j.biopha.2021.112176", "PMC8433040", "34562770"]}, {"Citation": "Khan A., Zia T., Suleman M., Khan T., Ali S.S., Abbasi A.A., Mohammad A., Wei D.Q. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data. J. Cell Physiol. 2021;236:7045\u20137057. doi: 10.1002/jcp.30367.", "ArticleIdList": ["10.1002/jcp.30367", "PMC8251074", "33755190"]}, {"Citation": "Pulliam J.R., van Schalkwyk C., Govender N., von Gottberg A., Cohen C., Groome M.J., Dushoff J., Mlisana K., Moultrie H. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. 2021 doi: 10.1101/2021.11.11.21266068.", "ArticleIdList": ["10.1101/2021.11.11.21266068"]}, {"Citation": "Wilhelm A., Widera M., Grikscheit K., Toptan T., Schenk B., Pallas C., Metzler M., Kohmer N., Hoehl S., Helfritz F.A. Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies. medRxiv. 2021 doi: 10.1101/2021.12.07.21267432.", "ArticleIdList": ["10.1101/2021.12.07.21267432"]}, {"Citation": "Roessler A., Riepler L., Bante D., von Laer D., Kimpel J. SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals. medRxiv. 2021 doi: 10.1101/2021.12.08.21267491.", "ArticleIdList": ["10.1101/2021.12.08.21267491", "PMC8781314", "35021005"]}, {"Citation": "Alamri M.A., Tahir Ul Qamar M., Mirza M.U., Bhadane R., Alqahtani S.M., Muneer I., Froeyen M., Salo-Ahen O.M. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro. J. Biomol. Struct. Dyn. 2021;39:4936\u20134948. doi: 10.1080/07391102.2020.1782768.", "ArticleIdList": ["10.1080/07391102.2020.1782768", "PMC7332866", "32579061"]}, {"Citation": "Alamri M.A., ul Qamar M.T., Mirza M.U., Alqahtani S.M., Froeyen M., Chen L.-L. Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches. J. Pharm. Anal. 2020;10:546\u2013559. doi: 10.1016/j.jpha.2020.08.012.", "ArticleIdList": ["10.1016/j.jpha.2020.08.012", "PMC7453225", "32874702"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016;3:237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Li F., Li W., Farzan M., Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309:1864\u20131868. doi: 10.1126/science.1116480.", "ArticleIdList": ["10.1126/science.1116480", "16166518"]}, {"Citation": "Goddard T.D., Huang C.C., Ferrin T.E. Software extensions to UCSF chimera for interactive visualization of large molecular assemblies. Structure. 2005;13:473\u2013482. doi: 10.1016/j.str.2005.01.006.", "ArticleIdList": ["10.1016/j.str.2005.01.006", "15766548"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Meng E.C., Couch G.S., Croll T.I., Morris J.H., Ferrin T.E. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382. doi: 10.1002/pro.3943.", "ArticleIdList": ["10.1002/pro.3943", "PMC7737788", "32881101"]}, {"Citation": "Song W., Gui M., Wang X., Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018;14:e1007236. doi: 10.1371/journal.ppat.1007236.", "ArticleIdList": ["10.1371/journal.ppat.1007236", "PMC6107290", "30102747"]}, {"Citation": "Diallo B.N.t., Glenister M., Musyoka T.M., Lobb K., Tastan Bishop \u00d6. SANCDB: An update on South African natural compounds and their readily available analogs. J. Cheminform. 2021;13:37. doi: 10.1186/s13321-021-00514-2.", "ArticleIdList": ["10.1186/s13321-021-00514-2", "PMC8097257", "33952332"]}, {"Citation": "Lagorce D., Bouslama L., Becot J., Miteva M.A., Villoutreix B.O. FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics. 2017;33:3658\u20133660. doi: 10.1093/bioinformatics/btx491.", "ArticleIdList": ["10.1093/bioinformatics/btx491", "28961788"]}, {"Citation": "Dallakyan S., Olson A.J. Chemical Biology. Springer; Berlin/Heidelberg, Germany: 2015. Small-Molecule Library Screening by Docking with PyRx; pp. 243\u2013250.", "ArticleIdList": ["25618350"]}, {"Citation": "Ravindranath P.A., Forli S., Goodsell D.S., Olson A.J., Sanner M.F. AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLOS Comput. Biol. 2015;11:e1004586. doi: 10.1371/journal.pcbi.1004586.", "ArticleIdList": ["10.1371/journal.pcbi.1004586", "PMC4667975", "26629955"]}, {"Citation": "Case D.A., Cheatham III T.E., Darden T., Gohlke H., Luo R., Merz Jr K.M., Onufriev A., Simmerling C., Wang B., Woods R.J. The Amber biomolecular simulation programs. J. Comput. Chem. 2005;26:1668\u20131688. doi: 10.1002/jcc.20290.", "ArticleIdList": ["10.1002/jcc.20290", "PMC1989667", "16200636"]}, {"Citation": "Wang J., Wang W., Kollman P.A., Case D.A. Antechamber: An accessory software package for molecular mechanical calculations. J. Am. Chem. Soc. 2001;222:U403."}, {"Citation": "Roe D.R., Cheatham T.E., III PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 2013;9:3084\u20133095. doi: 10.1021/ct400341p.", "ArticleIdList": ["10.1021/ct400341p", "26583988"]}, {"Citation": "Ahmad F., Albutti A., Tariq M.H., Din G., Tahir ul Qamar M., Ahmad S. Discovery of Potential Antiviral Compounds against Hendra Virus by Targeting Its Receptor-Binding Protein (G) Using Computational Approaches. Molecules. 2022;27:554. doi: 10.3390/molecules27020554.", "ArticleIdList": ["10.3390/molecules27020554", "PMC8779602", "35056869"]}, {"Citation": "Tahir ul Qamar M., Mirza M.U., Song J.-M., Rao M.J., Zhu X., Chen L.-L. Probing the structural basis of Citrus phytochrome B using computational modelling and molecular dynamics simulation approaches. J. Mol. Liq. 2021;340:116895. doi: 10.1016/j.molliq.2021.116895.", "ArticleIdList": ["10.1016/j.molliq.2021.116895"]}, {"Citation": "Muneer I., Ahmad S., Naz A., Abbasi S.W., Alblihy A., Aloliqi A.A., Alkhayl F.F., Alrumaihi F., Ahmad S., El Bakri Y. Discovery of Novel Inhibitors from Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation (VISTA) Front. Mol. Biosci. 2021:951. doi: 10.3389/fmolb.2021.716735.", "ArticleIdList": ["10.3389/fmolb.2021.716735", "PMC8576517", "34765641"]}, {"Citation": "ul Qamar M.T., Ahmad S., Khan A., Mirza M.U., Ahmad S., Abro A., Chen L.-L., Almatroudi A., Wei D.-Q. Structural probing of HapR to identify potent phytochemicals to control Vibrio cholera through integrated computational approaches. Comput. Biol. Med. 2021;138:104929. doi: 10.1016/j.compbiomed.2021.104929.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104929", "34655900"]}, {"Citation": "Altharawi A., Ahmad S., Alamri M.A., ul Qamar M.T. Structural insight into the binding pattern and interaction mechanism of chemotherapeutic agents with Sorcin by docking and molecular dynamic simulation. Colloids Surf. B Biointerfaces. 2021;208:112098. doi: 10.1016/j.colsurfb.2021.112098.", "ArticleIdList": ["10.1016/j.colsurfb.2021.112098", "34509085"]}, {"Citation": "Khan A., Ali S.S., Khan M.T., Saleem S., Ali A., Suleman M., Babar Z., Shafiq A., Khan M., Wei D.-Q. Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro) J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1779128.", "ArticleIdList": ["10.1080/07391102.2020.1779128", "PMC7309305", "32552361"]}, {"Citation": "Khan A., Heng W., Wang Y., Qiu J., Wei X., Peng S., Saleem S., Khan M., Ali S.S., Wei D.-Q. In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro) Phytother. Res. PTR. 2021;35:2841\u20132845. doi: 10.1002/ptr.6998.", "ArticleIdList": ["10.1002/ptr.6998", "PMC8013176", "33448101"]}, {"Citation": "Khan A., Kaushik A.C., Ali S.S., Ahmad N., Wei D.-Q. Deep-learning-based target screening and similarity search for the predicted inhibitors of the pathways in Parkinson\u2019s disease. RSC Adv. 2019;9:10326\u201310339. doi: 10.1039/C9RA01007F.", "ArticleIdList": ["10.1039/C9RA01007F"]}, {"Citation": "Khan A., Khan M., Saleem S., Babar Z., Ali A., Khan A.A., Sardar Z., Hamayun F., Ali S.S., Wei D.-Q. Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products. Interdiscip. Sci. Comput. Life Sci. 2020;12:335\u2013348. doi: 10.1007/s12539-020-00381-9.", "ArticleIdList": ["10.1007/s12539-020-00381-9", "PMC7332347", "32617855"]}, {"Citation": "Wang Y., Khan A., Chandra Kaushik A., Junaid M., Zhang X., Wei D.-Q. The systematic modeling studies and free energy calculations of the phenazine compounds as anti-tuberculosis agents. J. Biomol. Struct. Dyn. 2019;37:4051\u20134069. doi: 10.1080/07391102.2018.1537896.", "ArticleIdList": ["10.1080/07391102.2018.1537896", "30332914"]}, {"Citation": "Xue L.C., Rodrigues J.P., Kastritis P.L., Bonvin A.M., Vangone A. PRODIGY: A web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32:3676\u20133678. doi: 10.1093/bioinformatics/btw514.", "ArticleIdList": ["10.1093/bioinformatics/btw514", "27503228"]}, {"Citation": "Vangone A., Schaarschmidt J., Koukos P., Geng C., Citro N., Trellet M.E., Xue L.C., Bonvin A. Large-scale prediction of binding affinity in protein-small ligand complexes: The PRODIGY-LIG web server. Bioinformatics. 2019;35:1585\u20131587. doi: 10.1093/bioinformatics/bty816.", "ArticleIdList": ["10.1093/bioinformatics/bty816", "31051038"]}, {"Citation": "Mehmood I., Ijaz M., Ahmad S., Ahmed T., Bari A., Abro A., Allemailem K.S., Almatroudi A., Tahir ul Qamar M. SARS-CoV-2: An update on genomics, risk assessment, potential therapeutics and vaccine development. Int. J. Environ. Res. Public Health. 2021;18:1626. doi: 10.3390/ijerph18041626.", "ArticleIdList": ["10.3390/ijerph18041626", "PMC7915969", "33567746"]}, {"Citation": "Lall N., Kishore N., Momtaz S., Hussein A., Naidoo S., Nqephe M., Crampton B. Extract from Ceratonia siliqua Exhibits Depigmentation Properties. Phytother. Res. 2015;29:1729\u20131736. doi: 10.1002/ptr.5420.", "ArticleIdList": ["10.1002/ptr.5420", "26201055"]}, {"Citation": "Ayers S., Zink D.L., Mohn K., Powell J.S., Brown C.M., Murphy T., Brand R., Pretorius S., Stevenson D., Thompson D., et al. Flavones from Struthiola argentea with anthelmintic activity in vitro. Phytochemistry. 2008;69:541\u2013545. doi: 10.1016/j.phytochem.2007.08.003.", "ArticleIdList": ["10.1016/j.phytochem.2007.08.003", "17923139"]}, {"Citation": "Tshikalange T.E., Meyer J.J.M., Hussein A.A. Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J. Ethnopharmacol. 2005;96:515\u2013519. doi: 10.1016/j.jep.2004.09.057.", "ArticleIdList": ["10.1016/j.jep.2004.09.057", "15619572"]}, {"Citation": "van Heerden F.R., Viljoen A.M., van Wyk B.E. The major flavonoid of Dodonaea angustifolia. Fitoterapia. 2000;71:602\u2013604. doi: 10.1016/S0367-326X(00)00201-X.", "ArticleIdList": ["10.1016/S0367-326X(00)00201-X", "11449522"]}, {"Citation": "Adelekan A.M., Prozesky E.A., Hussein A.A., Ure\u00f1a L.D., van Rooyen P.H., Liles D.C., Meyer J.J.M., Rodr\u00edguez B. Bioactive Diterpenes and Other Constituents of Croton steenkampianus. J. Nat. Prod. 2008;71:1919\u20131922. doi: 10.1021/np800333r.", "ArticleIdList": ["10.1021/np800333r", "18855442"]}, {"Citation": "Sun H., Li Y., Tian S., Xu L., Hou T. Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys. Chem. Chem. Phys. 2014;16:16719\u201316729. doi: 10.1039/C4CP01388C.", "ArticleIdList": ["10.1039/C4CP01388C", "24999761"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "29"}, {"Year": "2022", "Month": "1", "Day": "31"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["35205124", "PMC8869371", "10.3390/biology11020258", "biology11020258"]}}], "PubmedBookArticle": []}